Thoracoamniotic Shunts: Fetal Treatment of Pleural Effusions and Congenital Cystic Adenomatoid Malformations

  title={Thoracoamniotic Shunts: Fetal Treatment of Pleural Effusions and Congenital Cystic Adenomatoid Malformations},
  author={R. Douglas Wilson and Jason K. Baxter and Mark Paul Johnson and M. E. King and Stefanie B. Kasperski and Timothy M. Crombleholme and Alan W. Flake and Holly L. Hedrick and L.J. Howell and N.S. Adzick},
  journal={Fetal Diagnosis and Therapy},
  pages={413 - 420}
Objective: To determine whether fetuses that underwent thoracoamniotic shunt placement for treatment of pleural effusion (PE) or macrocystic congenital cystic adenomatoid malformation (CCAM) have an improved outcome as compared with an untreated population. Methods: A retrospective review from a single tertiary center was performed using thoracoamniotic shunt placement to treat PE or macrocystic CCAM between 1998 and 2001. Thoracoamniotic shunts were used on 26 occasions in 19 pregnancies… 

Figures and Tables from this paper

Postnatal Chest Wall Deformities after Fetal Thoracoamniotic Shunting for Congenital Cystic Adenomatoid Malformation
TA shunting at less than 21 weeks of gestational age may result in postnatal chest wall deformity, and this observation should be discussed during counseling for this procedure.
Congenital Cystic Adenomatoid Malformation and Intrauterine Cystoamniotic Shunt
A 31-year-old woman carrying 22-weeks gestation fetus that has a large left-sided CCAM, severe mediastinal shift, and polyhydramnios admitted to the authors' clinic and delivered a female neonate, weighed 3150 gr by cesarean section, were uneventful.
Hemodynamic evaluation of a prenatal thoracoamniotic shunt for fetal pleural effusion.
Retrospective Review of Thoracoamniotic Shunting Using a Double-Basket Catheter for Fetal Chylothorax
Thoracoamniotic shunting should be considered for pleural effusion before development of fetal hydrops, or at least before the appearance of fetal ascites, and a double-basket catheter tends to be obstructive, but may be less invasive for fetuses.
Effect of Maternal Betamethasone Administration on Prenatal Congenital Cystic Adenomatoid Malformation Growth and Fetal Survival
In the fetus with a CCAM, the presence of hydrops fetalis or a CVR >1.6 is indicative of poor fetal outcome without prenatal intervention, and its potential to improve survival in high-risk groups is encouraging and warrants further controlled evaluations.
Percutaneous in utero thoracoamniotic shunt creation for fetal thoracic abnormalities leading to nonimmune hydrops.
Thoraco-amniotic shunting for fetal pleural effusion--a case series.
There is increasing evidence that in utero therapy with thoraco-amniotic shunting improves prognosis by allowing lung expansion thereby preventing hydrops and pulmonary hypoplasia.


Successful thoracoamniotic shunting and review of the literature in unilateral pleural effusion with hydrops
  • L. Wilkins-Haug, P. Doubilet
  • Medicine
    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
  • 1997
The experience and literature for the indications, complications, and outcomes after in utero thoracoamniotic shunt placement in two fetuses with unilateral pleural effusion complicated by hydrops are reviewed.
Mid-Trimester Thoracoamniotic Shunting for the Treatment of Fetal Primary Pleural Effusions in a Twin Pregnancy
A case of a twin pregnancy in which progressive pleural effusions and hydrops were diagnosed in one of the fetuses at 16 weeks of gestation is reported, and the first procedure of bilateral thoracoamniotic shunting was performed in the affected fetus.
Intrapartum drainage of fetal pleural effusion
It is concluded that intrapartum thoracocentesis seems to be a relatively simple procedure, that allows newborns with pleural effusion, to breathe spontaneously or be more easily ventilated, this in turn, reduces the need to introduce chest tubes in an emergency situation.
Percutaneous Laser Ablation of Fetal Congenital Cystic Adenomatoid Malformation: Too Little, Too Late?
The fetus with CCAM complicated by hydrops is already so compromised by the advanced state of the disease that insufficient time is available for necrotic tissue reabsorption after minimally invasive therapy with laser energy.
Outcome of the Prenatally Diagnosed Congenital Cystic Adenomatoid Lung Malformation: A Canadian Experience
CCAM can lead to fetal or neonatal demise from hydrops, lung hypoplasia, prematurity or severe associated malformations, but has a good prognosis in the majority of cases.
Respiratory function in infancy following pleuro-amniotic shunting.
It is suggested that pleuro-amniotic shunting may, be effective drainage of pleural effusion and hence prevention of chronic antenatal intrathoracic compression, avoid impairment of antenatal lung growth.
Feto‐amniotic shunting—report of the experience of four european centres
The application of an intrauterine shunt currently represents a rarely performed ultrasound‐guided therapeutic intervention in the fetus and a high complication rate restricts the application of drainage to selected cases.
A case of successful fetal therapy for congenital chylothorax by intrapleural injection of OK-432.
The pleural effusion was reduced by adhesion of the intrathoracic space and resulted in the delivery of a neonate who was healthy except for right renal dysfunction and Pulmonary hypoplasia was successfully prevented by OK-432.